Glatiramer Acetate Depot
Relapsing‑remitting Multiple Sclerosis
Phase 3Active
Key Facts
Indication
Relapsing‑remitting Multiple Sclerosis
Phase
Phase 3
Status
Active
Company
About Mapi Pharma
Israeli biotech developing long‑acting depot injectables for neurology and pain.
View full company profileAbout Mapi Pharma
Israeli biotech developing long‑acting depot injectables for neurology and pain.
View full company profile